Inventor · disambiguated record
Franziska Horling
Also filed as: HORLING FRANZISKA
8 granted patents·5 pending applications·12 citations·filing 2015–2023
80Inventor score
Top patents by PatentIndex Score
13 records- 0192US10189888B2Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia ABAXALTA INC·Filed 2016·Granted Jan 29, 2019·6 cites·38 claims
- 0285US10842853B2Viral vectors encoding recombinant fix with increased expression for gene therapy of hemophilia BBAXALTA INC·Filed 2018·Granted Nov 24, 2020·2 cites·25 claims
- 0376US10189889B2Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia ABAXALTA INC·Filed 2016·Granted Jan 29, 2019·2 cites·10 claims
- 0474US2022213172A1Viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia aTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 0573US11254731B2Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia ATAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Feb 22, 2022·0 cites·10 claims
- 0671US9873892B2Production of fully processed and functional factor X in a furin-secreting mammalian expression systemBAXALTA INC·Filed 2015·Granted Jan 23, 2018·2 cites·16 claims
- 0770US11492388B2Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia ATAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Nov 8, 2022·0 cites·19 claims
- 0870US2024100128A1Gene therapy of hemophilia b using viral vectors encoding recombinant fix variants with increased expressionTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 0963US11596671B2Gene therapy of hemophilia B using viral vectors encoding recombinant fix variants with increased expressionTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Mar 7, 2023·0 cites·16 claims
- 1062US2021128700A1Viral vectors encoding recombinant fix with increased expression for gene therapy of hemophilia bBAXALTA INC·Filed 2020·Application pending·0 cites
- 1148US2023043051A1Adeno-associated virus vectors based gene therapy for hereditary angioedemaSHIRE HUMAN GENETIC THERAPIES·Filed 2020·Application pending·0 cites
- 1248US2023055020A1Adeno associated virus based gene therapy for phenylketonuriaTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1344US10036002B2Factor X activationBAXALTA INC·Filed 2015·Granted Jul 31, 2018·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Franziska Horling files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →